586
1815584226014562116171
PŘEHLEDOVÝ3675207016974156235334409485586692777867
ČLÁNEK4580207016989163260360438521
Ces36997936014570127174
Urol38987936014578115180208
2020;41317936014562121178237261
24(3):44187936014561118151209238260
173–18247047936014561112171232285339398
5.62489601335677
Zachoval729896013360114163223283334387413
R.116989601335984
Mikční1281898013186108153200258279
dysfunkce1588898013160109149179238295341388439
u2055898013158
pacientů2141898013161111160181234292324381
s2546898013145
roztroušenou261589801313793135172204261319358411468527585
sklerózou.322489801314590114167198255297353411430
In:367889801312785102
Krhut380489801315992151208242
J,407089801314259
editor.4153898013157117139172228260274
Neurourologie.4455898013171124181212269327358415438496556578631648
Praha:624104801315586136194242260
Nakladatelství9081048013170119164188237297345377428451490524577600
Galén15321048013168118140193251
2005;18071048013154105160212226
11:2058104801315394105
77–83.21871048013154106155210261279
6.624119601335678
Khan7211196013359120172231
F,971119601335365
Pallant10551196013358108133157209268302
JF,1376119601334193105
Shea15001196013354113167219
TL,17381196013354105128
et1885119601335490
al.199411960133527799
Multiple21121198013185141163195217275298350
sclerosis:2481119801314189110162193249288308347364
prevalence2864119801316092142190239261313370418468
and33511198013150106165
factors3539119801312575122158213244284
impacting38471198013119106165214262297319375434
bladder4300119801316083131189248300330
and46501198013149106165
bowel48341198013160118196247269
function624134801312988146194230252310369
in1017134801312380
an11211348013150108
Australian12531348013164121160194226276298320368426
community17031348013149105195284341398420453505
cohort.22321348013149105163222254291310
Disabil2566134801317194133183242265287
Rehabil28771348013155109167215275298320
2009;32211348013153105160213231
31(19):34771348013153100121168213239256
1567–1576.3757134801315499151200249295340390438457
7.624149601335667
de7101496013361115
Seze8441496013354108154208
M,10711496013387111
Ruffion12011496013358117146176205265325
A,1545149601336690
Denys16541496013373127187236278
P,1951149601335867
et2037149601335490
al.214614960133527799
The22631498013151110162
neurogenic24441498013158111167198253312364421442490
bladder2953149801316083131189248300330
in3307149801311875
multiple34021498013189145166199220279301353
sclerosis:3775149801314088110161192248287308346363
review4161149801312879127149201278
of4459149801315785
the4568149801312986139
literature473014980131194073123153202234291321372
and6241648013150108167
proposal815164801316193149210269309359381
of1220164801315987
management13311648013191139197246305358447501558590
guidelines.19451648013160117139198251274295353406446466
Mult24351648013185143165198
Scler26571648013151100122175206
2007;28871648013154106161210223
13(7):3134164801315498125177206223
915–928.33811648013153102146202254304355374
8.624179601335781
Wyndaele7361796013394147209272325381407463
JJ,1222179601334989110
Kovindha13561796013368127179206267329390443
A,1831179601336893
Madersbacher19561796013389142205261297341404458507568623660
H,2647179601337396
et27671796013363100
al.2891179601336187110
Neurologic30331798013171125183214272295354415437486
urinary3543179801316799122180230261314
and38811798013159117177
faecal4083179801313788142192242265
incontinence.4373179801313189138195254286309367421479529580598
In:4995179801313290108
Abrams6241948013164124156206295335
P,983194801315963
Cardozo10741948013163113144202260302359
L,1457194801315373
Khoury15541948013159119177235266318
S,1896194801315573
Wein19971948013190140162220
A,2245194801316485
eds.23541948013157117157176
Incontinence,2554194801312885134190248280302360413471519570587
4th31651948013158322019540762055
Edition.32991948013155113135169191248307326
Plymouth:3649194801315980128218277335368426443
Health41201948013170123171193226284
Publication44281948013160116176199220268318350372430489
Ltd.4941194801315385142161
2009:6242098013154105160214232
793–960.8802098013154105154209262316369387
9.624224601335776
Krhut7232246013368105166226263
J,1009224601334970
Zapletalová11032246013369123185211266303356382443494547
O,1682224601337696
Zachoval18012246013369123172233293345398424
R,2248224601336792
et23642246013363100
al.2487224601336187109
Doporučení26282248013171131191251283342390441500521
pro31742248013169101158
diagnostiku3356224801316890139199257315356390413458517
a38972248013158
léčbu3979224801313285135194253
symptomů4256224801314999189249282339429486
dolních47662248013169127150208230278336
močových6242398013191151201257307359408467
cest11152398013158110151186
u13262398013167
pacientů14182398013170121170192246305337396
s18382398013150
roztroušenou1913239801314198142179212269328368422481540599
sklerózou2537239801314995120174206263306364423
v29842398013159
České30682398013171123164210263
republice3356239801314193154213273297319368420
–38012398013164
mezioborový38982398013191145190213272333394426484533586
mezioborový45172398013191145191214272334394427484533586
konsenzus6242548013147103162201254312356415454
expertů11022548013153101161215247284341
dle1467254801316082135
metodiky16262548013190143176232293315360411
DELPHI.20612548013172122170224291313332
Cesk24172548013163114154199
Slov2640254801315173131180
Neurol28442548013170123181212268291
N31592548013171
2017;32542548013153105153196209
80/-113(2):34882548013153107143171217258303329380407423
233–237.39352548013154107156212259312360367
10.6242696013356107129
Blok773269601336086146198
B,991269601336082
Castro‑Diaz10942696013364116159196231291327402428480527
D,1642269601337392
Del17552696013373128154
Popolo19302696013358116179240266326
G,2276269601337195
et2392269601335591
al.2504269601335378101
Neuro‑urology.26252698013170123181212269303363394450473531592640654
Arnhem,3300269801316496155212265354373
The36942698013151111164
Netherlands:38792698013170123156214268299322370428488527545
EAU44452698013151116181
Guidelines46472698013169127148208260283305362415455
Office;6242848013174103131159208258276
2019.9242848013153105153198213
11.6242996013356100117
McClurg7602996013387136199223282317377
D,1156299601337291
Ashe12662996013367111170225
RG,15102996013358128152
Marshall16812996013387140174218277329354378
K,2078299601335984
Lowe‑Strong21812996013352110189242278329363398456517577
AS.27772996013367121143
Comparison29392998013162118206265314345367405463520
of3479299801315886
pelvic35852998013160113135183206253
floor3858299801312653110168200
muscle40772998013190146185233254306
training,4407299801313061110131188209266325342
electro‑4769299801315375127176211243298333
myography6243148013190135192251282332390448494
biofeedback,1138314801316082140167219272332391440488533554
and17123148013149107165
neuromuscular18973148013159111168199255344400439487544566614645
electrical2561314801315376128177213244266314363385
stimulation296631480131407496184241262310342364421479
for3469314801312481112
bladder3601314801316183131190249301332
dysfunction39533148013160107147177235292340376397455512
in4489314801311976
people45853148013160114172232254307
with49123148013179101134191
multiple6243298013190147169203225284307360
sclerosis:1008329801314190112165196253293314353371
a14033298013150
randomized1477329801313282140199257347369413464524
pilot2025329801316184106164196
study.2245329801314176133193241255
Neurourol25243298013170123180212268326357414437
Urodyn.29853298013169100156217265324343
2006;33523298013154105160215232
25(4):36083298013154107132182207224
337–348.38563298013154103152200249303357377
12.6243446013356104127
Lucio7763446013352111160185245
AC,10453446013368128152
Campos12223446013364117208270331373
RM,16203446013359148172
Perissinotto18163446013359112147173215258283343403439477536
MC,23773446013388152176
et2577344601335692
al.2694344601335378100
Pelvic28193448013155106128177200249
floor3093344801312753111170202
muscle33203448013191148187236258311
training3655344801313567117139196218275335
in4014344801312482
the4120344801313593146
treatment4290344801313667119167199288342400431
of4747344801315887
lower4858344801312482161213244
urinary624359801315890112170219250302
tract950359801313466115164200
dysfunction11743598013160108149179237295344380402460518
in1716359801312381
women18213598013179137226280338
with21833598013179102135193
multiple24003598013190147169203225284307360
sclerosis.2784359801314190112165196253293314353373
Neurourol31813598013170123180212268326357414437
Urodyn36423598013169100156217265324
2010;39903598013154105153200219
29(8):42333598013153105133184210227
1410–1413.44843598013154100145193251297343389433451
13.6243746013356105126
McClurg7813746013388138201226286321382
D,1193374601337493
Ashe13163746013368112172227
RG,15673746013366137161
Lowe‑Strong17513746013359118198252288340374410469530591
AS.23733746013367122145
Neuromuscular25493748013170123181212269358415455503561583631663
electrical3236374801316183136185222253276324374396
stimulation3656374801314983105194251273322354376434492
and41723748013158115175
the4371374801314199152
treatment4547374801314274125173205295348406438
of5009374801316694
lower624389801312382160212244
urinary892389801316798121179228259311
tract1227389801314274124173210
dysfunction14613898013168116157187246304353389411469528
in2013389801313189
multiple21343898013190148170203226285308361
sclerosis2520389801314998120173204261301323362
–29063898013163
a29943898013158
double30763898013168126184244267320
blind,3421389801316892113171231249
placebo3694389801316992141190241301360
controlled,40783898013158114172204236293316338391451470
randomised4572389801314091149208266356378417471531
clinical62440480131497193150172220270292
trial.94040480131346689137159177
Neurourol11414048013171124181212269327358415438
Urodyn16034048013169100156216265324
2008;19514048013154105160214231
27(3):22064048013154104127178203219
231–237.24504048013153106152202249302350357
14.6244196013356106128
Fjorback775419601335478138174236289338389
MV,11874196013388148164
Van13744196013362111172
Rey15694196013359114165
FS,17574196013353105127
Rijkhoff1907419601336085111162224284316348
NJM,22784196013372113201225
et2526419601335591
al.2640419601335378101
Electrical2765419801315173126175211243266314364386
stimulation317541980131417597186243265314346368426484
of3683419801315887
sacral3794419801314191139171221243
dermatomes40614198013160112144234283315371460514554
in4639419801312280
multiple47434198013190147169202224284307360
sclerosis624434801314190112165196253293314353
patients10014348013161111143165217275307349
with13744348013179102135193
neurogenic15914348013159112170201258318371429450499
detrusor21144348013159112145177235275333365
overactivity.25034348013159107159190240289325347396419452504517
Neurourol30444348013170123181212269327358414438
Urodyn3506434801316899156216264324
2007;38544348013153105160209222
26(4):41004348013154105132182207224
525–530.43484348013154104157212263313365383
15.6244496013356105126
Centonze7724496013363117177213272332379434
D,1227449601337493
Petta13414496013359112148187240
F,1602449601335466
Versace16904496013361112148192245294347
V,2059449601336177
et2158449601335591
al.2271449601335378101
Effects2394449801315179109161210247288
of2705449801315887
motor28144498013190148181237269
cortex31054498013149105137174225273
rTMS3402449801313074159209
on36334498013159117
lower3774449801312280158210242
urinary4038449801315890112170219250302
tract4364449801313264114162199
dysfunction45854498013160108149178237295343380402459518
in624464801312381
multiple7294648013190147169202224284307360
sclerosis.1113464801314189112164196252292314353372
Mult15094648013186143165199
Scler17324648013151100122174206
2007;19624648013154105160209222
13(2):2208464801315499125176203219
269–271.24514648013154105156213261310359372
16.6244796013356106128
Nasios7724796013372124166190250292
G,1083479601337195
Messinis11974796013388143185227252311336378
L,1594479601335275
Dardiotis16884796013373125160220245305340364406
E,2114479601335376
Papathanasopoulos22094796013358109170223258318369429481523583645705765790849892
P.3120479601335868
Repetitive32074798013155108167220253275308329378430
Transcranial3656479801315176125182221269300350407428476498
Magnetic41744798013185134192250302335357404
Stimulation,4598479801315182103191248270318350371429486504
Cognition,6244948013163119179237259292314372430448
and10964948013150108167
Multiple12884948013185143165198220279303355
Sclerosis:16674948013152100122175207263303324363381
An20724948013165123
Overview.22194948013174124176208260283336414429
Behav26724948013156109167216264
Neurol29604948013170123180212268291
2018;32754948013154106153200217
doi:35164948013160118140157
10.1155/2018/8584653.36974948013154101119165206250299335388439487533571623674726781836887937955
17.6245096013356104115
De7705096013374129
Ridder923509601336792154216271307
D,1261509601337493
Ost13855096013376119156
D,1572509601337393
Van16885096013369119180
der18915096013370125161
Aa20835096013367120
F,2226509601336274
et2323509601336399
al.2446509601336186108
Conservative25785098013171127186225278310363413445467516568
bladder3170509801316992141201260313345
management35475098013190139197246305358447501558590
in4161509801313189
advanced42745098013158118167217275324375435
multiple47415098013190148170203225285308361
sclerosis.624524801314190112165196253293314353372
Mult10205248013186144166199
Scler12435248013151100122175206
2005;14735248013154105160212227
11(6):1724524801315494116166192209
694–699.19575248013154105159216273324378393
18.6245396013356106129
Krhut772539601335995155214250
J,1041539601334161
Borovicka11225396013359119154213264289337387440
V,1581539601336177
Bilkova1677539601335984109159217268320
K20165396013359
et2095539601335490
al.2204539601335378100
Efficacy2323539801315176104132180229277327
and26705398013150107166
safety2855539801314191118170202253
of3128539801315886
mirabegron32345398013189110141190249303362393449507
for3765539801312481112
the3901539801313087140
treatment4064539801313061112160191280332390421
of4505539801315886
neurogenic46115398013158111167198254314366423444492
detrusor6245548013159111144175233271329360
overactivity‑prospective,1004554801315810515718723728432034239041344549652858862067571577382687591193298110321048
randomized,2076554801312877134193250339360403454513531
double‑blind,26275548013159116173232255307341401424445502560578
placebo‑controlled3224554801316183131179229288347381431486544575607662685706758818
study.4061554801314175132191238251
Neurourol43325548013170122179209265322353409431
Urodyn4783554801316898154214261320
2018;6245698013154105153199217
37(7):8655698013153101125177206223
2226–2233.11125698013154106159210268315368420470488
19.6245846013356105123
Valiquette7675846013361110135159220279334370408461
G,1247584601337194
Herbert13615846013371126161223278313352
J,1732584601334061
Maede‑D‚18125846013388141195257311347421440
Alisera2271584601336792116158213248301
P.2591584601335868
Desmopressin26785848013171124164251309369400451491530551608
in3310584801311976
the3410584801313087139
management35695848013190138195244302355443496553584
of4173584801315886
nocturia42795848013159116165201258289311359
in4662584801311976
patients47585848013160109141163215272303345
with6245998013179102135193
multiple8415998013191148170203225285308360
sclerosis.1226599801314189111164196252292313352372
A16225998013164
double‑blind,17105998013160118176236259312346407431452510569587
crossover2321599801314981137177217275323375407
trial.275259980131346588136159177
Arch2953599801316496143200
Neurol31775998013171124181212269292
1996;3493599801315499152206224
53(12):37415998013153103130177222248264
1270–1275.4029599801315499148198256302347397446463
20.6246146013356111133
Odeh7776146013376139194255
M,10526146013389113
Oliven11856146013376102127180233294
A.1500614601336792
Coma16136148013163119208257
and18916148013150108168
seizures2083614801313891113157215246298338
due24426148013160117170
to2636614801313187
severe2747614801313891140192223275
hyponatremia30436148013159105166225283332364396448537558607
and36716148013150108167
water38596148013180129161212244
intoxication4127614801312078109165211233282331364386443502
in4653614801312078
an47526148013150107
adult48816148013150109166188221
with6246298013179102135193
intranasal841629801312381113145194252301341391413
desmopressin12786298013160113153242300360392444484524545603
therapy1905629801313492145176226286333
for2262629801312986118
nocturnal24046298013159117167203261292351400422
enuresis.28506298013153111168200251291313352371
J32456298013138
Clin3307629801316385106164
Pharmacol34956298013155112161192282331379435458
2001;39786298013153105160208218
41(5):4220629801315499120171198214
582–584.44596298013153105156207259310366384
21.6246446013356107124
Abo7686446013367129190
Youssef9786446013359113173216258313346
N,1343644601337396
Schneider14586446013355104164224279305366421457
MP,19356446013388146156
Mordasini21116446013388149185246298341365426451
L,2581644601335276
et2677644601335591
al.2788644601335378101
Cannabinoids29096448013163112170228276336359416474497556595
for3528644801312582114
treating3666644801313162114162194216274333
neurogenic40196448013159112170201257318371428450498
lower4541644801312078156208240
urinary4801644801315990112170219250302
tract624659801313466116164200
dysfunction8506598013160108149178237295344380402460518
in1392659801312582
patients15006598013161111143165217275307349
with18746598013180102136194
multiple20936598013190148170203225284308360
sclerosis:2477659801314392114167198255295316355372
a28746598013151
systematic2949659801314392133167218307356388410458
review3432659801313485134157209288
and37446598013151109168
meta‑analysis.39386598013190143176226260308366415437485526547586605
BJU4569659801315692160
Int4753659801312583114
2017;48936598013154105153197210
119(4):624674801315494139168217242259
515–521.9076748013154100145200252302349361
22.6246896013356112135
Francomano782689601335386139199248307398451511571
D,1376689601337393
Ilacqua1492689601332651104152213273325
A,1840689601336792
Cortese19556896013364122158197251294349
A,2327689601336792
et2442689601335591
al.2556689601335378101
Effects2680689801315179109161210247288
of2992689801315887
daily31036898013159108130152200
tadalafil3327689801313383142191213262288314336
on36876898013158117
lower3828689801312381159211243
urinary4094689801315990112170219250302
tract4420689801313365115164200
symptoms4644689801314190180240272328418458
in624704801312381
young7297048013157115173231291
men10537048013190144202
with12887048013180102136195
multiple15157048013191148170204226286310363
sclerosis1902704801315099121174206263303325364
and22907048013159117177
erectile2491704801316294146196232254277330
dysfunction:28457048013168117158188247305354391413471530548
a34177048013158
pilot3500704801316992114172205
study.3729704801315084143202251265
J40197048013146
Endocrinol40897048013160118177236286318340398457481
Invest4594704801313190137189230265
2017;48837048013162114162206220
40(3):6247198013154108137188213229
275–279.8787198013153103152207255304355370
23.6247346013356112134
Schroder7817346013354103164199258321376411
A,1216734601336792
Albrecht1331734601336793154190245294355390
U,1744734601337191
Schnitker18587346013354104164224249285336389425
J,2306734601334162
Reitz23917346013359114140176225
A,2639734601336792
Stein2754734601335589142168228
R.3005734601336085
Efficacy,3113734801315177105133182232280331344
safety,3481734801314191119171204256269
and37747348013150108167
tolerability3965734801313490113166197247307330351373406458
of4447734801315887
intravesically4558734801312380112144194241293333355403453475497544
administered6247498013150109198219277298337371422453505565
0.1%1209749801315471117190
oxybutynin14197498013159104155216273307358417438496
hydrochloride19357498013159105163194250299357379437469491550603
solution2558749801314199122178212234291350
in2931749801312077
adult30287498013150109166188221
patients32697498013161111143165217275306348
with36377498013179102135193
neurogenic38507498013159111169200256316369426448496
bladder:4366749801316184132191251303335354
a47417498013149
rando‑4814749801312979136195253289
mized,6247648013190112156207267285
prospective,934764801316092149189248302352388410459511528
controlled14867648013149105163195227283306328381441
multi‑center19517648013190147170203225258309360418449500532
trial.250776480131346688137159177
Neurourol27087648013170124181212269327358414438
Urodyn3170764801316999156216264324
2016;35187648013153105153199217
35(5):37597648013153103129179206223
582–588.40067648013154105156208259311365384